Prevalence of cervical intraepithelial neoplasia grades II/III and cervical cancer in patients with cytological diagnosis of atypical squamous cells when high-grade intraepithelial lesions (ASC-H) cannot be ruled out
Keywords:
Cytology, Colposcopy, Cervical intraepithelial neoplasia, Uterine cervical neoplasm, Cervix uteriAbstract
CONTEXT AND OBJECTIVE: The latest update of the Bethesda System divided the category of atypical squamous cells of undetermined significance (ASCUS) into ASC-US (undetermined significance) and ASC-H (high-grade intraepithelial lesion cannot be ruled out). The aims here were to measure the prevalence of pre-invasive lesions (cervical intraepithelial neoplasia, CIN II/III) and cervical cancer among patients referred to Instituto Fernandes Figueira (IFF) with ASC-H cytology, and compare them with ASC-US cases. DESIGN AND SETTING: Cross-sectional study with retrospective data collection, at the IFF Cervical Pathology outpatient clinic. METHODS: ASCUS cases referred to IFF from November 1997 to September 2007 were reviewed according to the 2001 Bethesda System to reach cytological consensus. The resulting ASC-H and ASC-US cases, along with new cases, were analyzed relative to the outcome of interest. The histological diagnosis (or cytocolposcopic follow-up in cases without such diagnosis) was taken as the gold standard. RESULTS: The prevalence of CIN II/III in cases with ASC-H cytology was 19.29% (95% confidence interval, CI, 9.05-29.55%) and the risk of these lesions was greater among patients with ASC-H than with ASC-US cytology (prevalence ratio, PR, 10.42; 95% CI, 2.39-45.47; P = 0.0000764). Pre-invasive lesions were more frequently found in patients under 50 years of age with ASC-H cytology (PR, 2.67; 95% CI, 0.38-18.83); P = 0.2786998). There were no uterine cervical cancer cases. CONCLUSION: The prevalence of CIN II/III in patients with ASC-H cytology was significantly higher than with ASC-US, and division into ASC diagnostic subcategories had good capacity for discriminating the presence of pre-invasive lesions.
Downloads
References
The 1988 Bethesda System for reporting cervical/vaginal cytological diagnoses. Nacional Cancer Institute Workshop. JAMA. 1989;262(7):931-4.
Cox JT. Management of women with cervical cytology interpreted as ASC-US or as ASC-H. Clin Obstet Gynecol. 2005;48(1):160-77.
Kurman RJ, Henson DE, Herbst AL, Noller KL, Schiffman MH. Interim guidelines for manage- ment of abnormal cervical cytology. The 1992 National Cancer Institute Workshop. JAMA. 1994;271(23):1866-9.
ASCUS-LSIL Traige Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol. 2003;188(6):1383-92.
Apgar BS, Zoschnick L, Wright TC Jr. The 2001 Bethesda System terminology. Am Fam Physi- cian. 2003;68(10):1992-8.
Wright TC Jr, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ; ASCCP-Sponsored Consensus Con- ference. 2001 Consensus Guidelines for the management of women with cervical cytologi- cal abnormalities. JAMA. 2002;287(16):2120-9.
Berek JS. Simplification of the new Bethesda 2001 classification system. Am J Obstet Gy- necol. 2003;188(3 Suppl):S2-5; discussion S6-7.
Kurman RJ, Solomon D. Anormalidades das células epiteliais. In: Kurman RJ, Solomon D, editors. O sistema Bethesda para o relato de diagnóstico citológico cervicovaginal: defini- ções, critérios e notas explicativas para terminologia e amostra adequada. Rio de Janeiro: Revinter; 1997. p. 28-41.
Sherman ME, Abdul-Karim FW, Berek JS, Powers CN, Sidawy MK, Tabbara SO. Atypical squa- mous cells. In: Solomon D, Nayar R, editors. The Bethesda system for reporting cervical cytolo- gy: definitions, criteria and explanatory notes. New York: Springer-Verlag; 2004. p. 67-87.
Richart RM. A modified terminology for cervical intraepithelial neoplasia. Obstet Gynecol. 1990;75(1):131-3.
Wright TC Jr, Massad LS, Dunton CJ, et al. 2006 consensus guidelines for the management of wo- men with abnormal cervical cancer screening tests. Am J Obstet Gynecol. 2007;197(4):346-55.
Brasil. Ministério da Saúde. Secretaria de Atenção à Saúde. Instituto Nacional do Câncer. Coor- denação de Prevenção e Vigilância. Nomenclatura brasileira para laudos cervicais e condutas preconizadas: recomendações para profissionais de saúde. 2a ed. Rio de Janeiro: INCA; 2006. Available from: http://www.portalsbc.com.br/nomeclaturas.pdf. Accessed in 2009 (Oct 7).
Selvaggi SM. Reporting of atypical squamous cells, cannot exclude a high-grade squa- mous intraepithelial lesion (ASC-H) on cervical samples: is it significant? Diagn Cytopathol. 2003;29(1):38-41.
Alli PM, Ali SZ. Atypical squamous cells of undetermined significance--rule out high-grade squamous intraepithelial lesion: cytopathologic characteristics and clinical correlates. Diagn Cytopathol. 2003;28(6):308-12.
Louro AP, Roberson J, Eltoum I, Chhieng DC. Atypical squamous cells, cannot exclude high- grade squamous intraepithelial lesion. A follow-up study of conventional and liquid-based preparations in a high-risk population. Am J Clin Pathol. 2003;120(3):392-7.
Wang Y, Bian ML, Liu J. [Comment on diagnosis of atypical squamous cells using new the Bethesda system 2001]. Zhonghua Fu Chan Ke Za Zhi. 2004;39(1):27-9.
Duncan LD, Jacob SV. Atypical squamous cells, cannot exclude a high-grade squamous intraepithelial lesion: the practice experience of a hospital-based reference laboratory with this new Bethesda system diagnostic category. Diagn Cytopathol. 2005;32(4):243-6.
Simsir A, Ioffe O, Sun P, Elgert P, Cangiarella J, Levine PH. Effect of Bethesda 2001 on reporting of atypical squamous cells (ASC) with special emphasis on atypical squamous cells-cannot rule out high grade (ASC-H). Diagn Cytopathol. 2006;34(1):62-6.
McHale MT, Souther J, Elkas JC, Monk BJ, Harrison TA. Is atypical squamous cells that cannot exclude high-grade squamous intraepithelial lesion clinically significant? J Low Genit Tract Dis. 2007;11(2):86-9.
Lee SJ, Jung KL, Lee JW, et al. Analyses of atypical squamous cells refined by the 2001 Bethesda System: the distribution and clinical significance of follow-up management. Int J Gynecol Cancer. 2006;16(2):664-9.
Saad RS, Dabbs DJ, Kordunsky L, et al. Clinical significance of cytologic diagnosis of atypi- cal squamous cells, cannot exclude high grade, in perimenopausal and postmenopausal women. Am J Clin Pathol. 2006;126(3):381-8.
Prendiville W. Large loop excision of the transformation zone. Clin Obstet Gynecol. 1995;38(3):622-39.
Sherman ME, Castle PE, Solomon D. Cervical cytology of atypical squamous cells--cannot exclude high-grade squamous intraepithelial lesion (ASC-H): characteristics and histologic outcomes. Cancer. 2006;108(5):298-305.
Jones BA, Novis DA. Follow-up of abnormal gynecologic cytology: a college of American pathologists Q-probes study of 16132 cases from 306 laboratories. Arch Pathol Lab Med. 2000;124(5):665-71.
